86 related articles for article (PubMed ID: 22176792)
1. Unscheduled bleeding with continuous oral contraceptive pills: a comparison of progestin dose.
Kaneshiro B; Edelman A; Carlson NE; Nichols M; Jensen J
Contraception; 2012 Jul; 86(1):22-7. PubMed ID: 22176792
[TBL] [Abstract][Full Text] [Related]
2. Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial.
Teichmann A; Apter D; Emerich J; Greven K; Klasa-Mazurkiewicz D; Melis GB; Spaczynski M; Grubb GS; Constantine GD; Spielmann D
Contraception; 2009 Dec; 80(6):504-11. PubMed ID: 19913143
[TBL] [Abstract][Full Text] [Related]
3. A comparison between monophasic levonorgestrel-ethinyl estradiol 150/30 and triphasic levonorgestrel-ethinyl estradiol 50-75-125/30-40-30 contraceptive pills for side effects and patient satisfaction: a study in Iran.
Kashanian M; Shahpourian F; Zare O
Eur J Obstet Gynecol Reprod Biol; 2010 May; 150(1):47-51. PubMed ID: 20185226
[TBL] [Abstract][Full Text] [Related]
4. Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.
Ahrendt HJ; Makalová D; Parke S; Mellinger U; Mansour D
Contraception; 2009 Nov; 80(5):436-44. PubMed ID: 19835717
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of subantimicrobial-dose doxycycline to prevent unscheduled bleeding with continuous oral contraceptive pill use.
Kaneshiro B; Edelman A; Carlson NE; Nichols M; Forbes MM; Jensen J
Contraception; 2012 Apr; 85(4):351-8. PubMed ID: 22067758
[TBL] [Abstract][Full Text] [Related]
6. Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study.
Merz M; Kroll R; Lynen R; Bangerter K
Contraception; 2015 Feb; 91(2):113-20. PubMed ID: 25453585
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.
Weisberg E; Merki-Feld GS; McGeechan K; Fraser IS
Contraception; 2015 Feb; 91(2):121-6. PubMed ID: 25459098
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive.
Portman DJ; Kaunitz AM; Howard B; Weiss H; Hsieh J; Ricciotti N
Contraception; 2014 Apr; 89(4):299-306. PubMed ID: 24576794
[TBL] [Abstract][Full Text] [Related]
9. Oestrogen treatment for increased bleeding in Norplant users: preliminary results.
Witjaksono J; Lau TM; Affandi B; Rogers PA
Hum Reprod; 1996 Oct; 11 Suppl 2():109-14. PubMed ID: 8982752
[TBL] [Abstract][Full Text] [Related]
10. Safety and bleeding profile of continuous levonorgestrel 90 mcg/ethinyl estradiol 20 mcg based on 2 years of clinical trial data in Canada.
Reid RL; Fortier MP; Smith L; Mirkin S; Grubb GS; Constantine GD
Contraception; 2010 Dec; 82(6):497-502. PubMed ID: 21074011
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results.
Archer DF; Jensen JT; Johnson JV; Borisute H; Grubb GS; Constantine GD
Contraception; 2006 Dec; 74(6):439-45. PubMed ID: 17157099
[TBL] [Abstract][Full Text] [Related]
12. Reference period analysis of vaginal bleeding with triphasic oral contraceptive agents containing norethindrone or levonorgestrel: a comparison study.
Schwarz BE; Pierce C; Walden CE; Knopp RH
Int J Fertil; 1992; 37(3):176-82. PubMed ID: 1355765
[TBL] [Abstract][Full Text] [Related]
13. Bleeding pattern with drospirenone 3 mg+ethinyl estradiol 20 mcg 24/4 combined oral contraceptive compared with desogestrel 150 mcg+ethinyl estradiol 20 mcg 21/7 combined oral contraceptive.
Anttila L; Kunz M; Marr J
Contraception; 2009 Nov; 80(5):445-51. PubMed ID: 19835718
[TBL] [Abstract][Full Text] [Related]
14. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given?
Edelman AB; Koontz SL; Nichols MD; Jensen JT
Obstet Gynecol; 2006 Mar; 107(3):657-65. PubMed ID: 16507938
[TBL] [Abstract][Full Text] [Related]
15. Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive.
Kaunitz AM; Portman DJ; Hait H; Reape KZ
Contraception; 2009 May; 79(5):350-5. PubMed ID: 19341846
[TBL] [Abstract][Full Text] [Related]
16. Clinical and biochemical investigations of a variable-dose combined type oral contraceptive.
Briggs MH; Briggs M
Curr Med Res Opin; 1977; 5(3):213-6. PubMed ID: 162656
[TBL] [Abstract][Full Text] [Related]
17. Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium.
Franceschini SA; Vieira CS; Martins WP; França JB; Ferriani RA
Contraception; 2013 Jun; 87(6):766-72. PubMed ID: 23102798
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.
Akerlund M
Acta Obstet Gynecol Scand Suppl; 1997; 164():63-5. PubMed ID: 9225641
[TBL] [Abstract][Full Text] [Related]
19. Abnormal uterine bleeding associated with hormonal contraception.
Schrager S
Am Fam Physician; 2002 May; 65(10):2073-80. PubMed ID: 12046776
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of metrorrhagia, breakthrough bleeding and spotting under contraceptives].
Gompel A
J Gynecol Obstet Biol Reprod (Paris); 2008 Dec; 37 Suppl 8():S356-64. PubMed ID: 19268214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
